Cadila Pharmaceuticals, with its 400 multi-dimensional product formulations, spanning all major therapeutic groups in Human and 15 in Animal Health is a leader amongst the Indian Pharma Companies.

Continuous improvement of process efficiency is carried out, resulting in:

• Being the first to market several new and difficult formulations

• Percentage of rework being close to zero

• Process innovation to reduce the number of steps, while increasing yield

•  Ongoing effort to improve raw material utilization

• Standardization of base used in all creams & suspensions

• Tremendous cost benefit to customers